News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,661 Results
Type
Article (8002)
Company Profile (142)
Press Release (478246)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166746)
Career Advice (303)
Deals (25742)
Drug Delivery (7)
Drug Development (52876)
Employer Resources (14)
FDA (9761)
Job Trends (8568)
News (238212)
Policy (17892)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (492)
Accelerated approval (27)
ADA (18)
Adcomms (1)
Allergies (99)
Alliances (33156)
ALS (114)
Alzheimer's disease (990)
Antibody-drug conjugate (ADC) (295)
Approvals (10434)
Artificial intelligence (345)
ASCO (160)
Autoimmune disease (228)
Automation (30)
Bankruptcy (263)
Belgium (3)
Best Places to Work (6958)
BIO (36)
Biologics (14)
BIOSECURE Act (1)
Biosimilars (119)
BioSpace Insights (17)
Biotechnology (90)
Bispecific (3)
Bladder cancer (140)
Brain cancer (33)
Breast cancer (522)
Cancer (3832)
Cardiovascular disease (231)
Career advice (245)
Career pathing (1)
CAR-T (182)
CDC (1)
CDMO (21)
Celiac Disease (1)
Cell therapy (497)
Cervical cancer (35)
Clinical research (48174)
Collaboration (1308)
Commercialization (6)
Compensation (1552)
Complete response letters (35)
COVID-19 (765)
CRISPR (65)
C-suite (821)
Cystic fibrosis (87)
Data (5998)
Denatured (4)
Depression (108)
Dermatology (80)
Diabetes (364)
Diagnostics (4230)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (162)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (171)
Earnings (73780)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88259)
Executive appointments (721)
FDA (12559)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (19)
Frontotemporal dementia (24)
Funding (971)
Gene editing (127)
Generative AI (11)
Gene therapy (341)
GLP-1 (299)
Government (948)
Grass and pollen (2)
Guidances (281)
Healthcare (9369)
Hematology (94)
HIV (55)
Huntington's disease (23)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (70)
Immunology and inflammation (111)
Immuno-oncology (62)
Indications (169)
Infectious disease (959)
Inflammatory bowel disease (131)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (266)
Interviews (41)
IPO (12391)
IRA (2)
Job creations (1969)
Job search strategy (235)
JPM (1)
Kidney cancer (17)
Kidney disease (47)
Labor market (1)
Layoffs (59)
Legal (5195)
Licensing (24)
Liver cancer (46)
Longevity (20)
Lung cancer (555)
Lung diease (8)
Lymphoma (261)
Machine learning (29)
Management (3)
Manufacturing (589)
Marketing (9)
MASH (118)
Medical affairs (2)
Medical device (8697)
Medtech (8860)
Mergers & acquisitions (14427)
Metabolic disorders (740)
mRNA (69)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (229)
Neuropsychiatric disorders (40)
Neuroscience (1892)
NextGen: Class of 2026 (3150)
Non-profit (843)
Obesity (235)
Opinion (10)
Ovarian cancer (169)
Pain (179)
Pancreatic cancer (213)
Parkinson's disease (211)
Partnered (12)
Patents (509)
Patient advocacy (1)
Patient recruitment (534)
Patient selection (14)
Peanut (33)
People (41422)
Peptides (5)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15554)
Phase 2 (21514)
Phase 3 (14519)
Pipeline (7951)
Policy (18)
Postmarket research (1570)
Preclinical (6565)
Press Release (34)
Prostate cancer (196)
Psychedelics (9)
Radiopharmaceuticals (198)
Rare diseases (601)
Real estate (3024)
Recruiting (6)
Regenerative medicine (7)
Regulatory (15053)
Reports (23)
Research institute (586)
Resumes & cover letters (45)
Rett syndrome (44)
RNA editing (7)
RSV (48)
Schizophrenia (104)
Series A (170)
Series B (125)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (91)
Sponsored (5)
Startups (2021)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (51)
Vaccines (336)
Venture capital (18)
Weight loss (76)
Wet AMD (1)
Women's health (91)
Date
Today (8)
Last 7 days (350)
Last 30 days (1318)
Last 365 days (19031)
2026 (14262)
2025 (19251)
2024 (22990)
2023 (26539)
2022 (34587)
2021 (37153)
2020 (33469)
2019 (23239)
2018 (17468)
2017 (18765)
2016 (17920)
2015 (24265)
2014 (21681)
2013 (18139)
2012 (20227)
2011 (20440)
2010 (20332)
Location
Africa (227)
Alabama (80)
Alaska (2)
Arizona (313)
Arkansas (10)
Asia (17970)
Australia (2095)
California (12516)
Canada (3283)
China (557)
Colorado (509)
Connecticut (435)
Delaware (218)
Europe (24661)
Florida (1885)
Georgia (396)
Hawaii (3)
Idaho (46)
Illinois (740)
India (54)
Indiana (326)
Iowa (16)
Japan (437)
Kansas (104)
Kentucky (33)
Louisiana (27)
Maine (27)
Maryland (1245)
Massachusetts (8198)
Michigan (315)
Minnesota (578)
Mississippi (4)
Missouri (83)
Montana (20)
Nebraska (11)
Nevada (125)
New Hampshire (60)
New Jersey (2747)
New Mexico (12)
New York (2938)
North Carolina (1325)
North Dakota (4)
Northern California (6299)
Ohio (298)
Oklahoma (14)
Oregon (16)
Pennsylvania (2329)
Puerto Rico (24)
Rhode Island (30)
South America (403)
South Carolina (78)
South Dakota (1)
Southern California (5221)
Tennessee (125)
Texas (2053)
United States (40578)
Utah (377)
Vermont (1)
Virginia (160)
Washington D.C. (39)
Washington State (967)
West Virginia (1)
Wisconsin (78)
Wyoming (1)
486,661 Results for "aerovance inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pulmongene Appoints Hunter C. Gillies, M.B.Ch.B, as Chief Medical Officer to Lead Global Clinical Development in Fibrotic and Pulmonary Diseases
— Veteran Physician-Scientist Brings Over 25 Years of Pulmonary and Cardiopulmonary Clinical Development Leadership Spanning Pfizer, Gilead, and Aerovate Therapeutics —
July 6, 2026
·
1 min read
Business
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, today announced financial results for the quarter ended March 31, 2024, and recent business highlights.
May 13, 2024
·
9 min read
Business
Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board Chair
Aerovate Therapeutics, Inc. today announced that its Board of Directors has elected current Board member, Habib Dable, as Chair of the Board.
March 6, 2024
·
6 min read
Press Releases
Aerovate Therapeutics Stockholders Approve Proposed Merger with Jade Biosciences and All Related Proposals
April 21, 2025
·
10 min read
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26
October 1, 2026
·
2 min read
Business
Aerovate Therapeutics Announces Third Quarter Financial Results and Business Highlights
Aerovate Therapeutics, Inc. today announced financial results for the quarter ended September 30, 2023, and recent business highlights.
November 13, 2023
·
8 min read
Business
Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlights
Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, today announced financial results for the year ended December 31, 2023, and recent business highlights.
March 25, 2024
·
11 min read
Business
Aerovate Therapeutics Appoints Habib Dable To Its Board of Directors
Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, announced the appointment of Habib Dable as a member of Aerovate’s Board of Directors.
July 11, 2023
·
4 min read
Press Releases
Aerovate Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Jade Biosciences
April 10, 2025
·
11 min read
Press Releases
Aerovate Therapeutics Announces Range of Expected Cash Dividend in Connection with the Proposed Merger with Jade Biosciences
April 7, 2025
·
10 min read
1 of 48,667
Next
